Gliosarcoma with extensive extracranial metastatic spread and familial coincidence: A case report.


Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 06 01 2023
revised: 02 03 2023
accepted: 03 03 2023
medline: 11 4 2023
pubmed: 12 3 2023
entrez: 11 3 2023
Statut: ppublish

Résumé

Gliosarcoma is a rare histopathological subtype of glioblastoma. Metastatic spreading is unusual. In this report, we illustrate a case of gliosarcoma with extensive extracranial metastases with confirmation of histological and molecular concordance between the primary tumor and a metastatic lesion of the lung. Only the autopsy revealed the extent of metastatic spread and the hematogenous pattern of metastatic dissemination. Moreover, the case bared a familial coincidence of malignant glial tumors as the patient's son was diagnosed with a high-grade glioma shortly after the patient's death. By molecular analysis (Sanger and next generation panel sequencing), we could confirm that both patient's tumors carried mutations in the TP53 gene. Interestingly, the detected mutations were located in different exons. Altogether, this case draws attention to the fact that sudden clinical aggravation could be caused by the rare phenomenon of metastatic spread and should therefore be always taken into consideration, even at an early disease stage. Furthermore, the presented case highlights the contemporary value of autoptic pathological examination.

Identifiants

pubmed: 36905695
pii: S0344-0338(23)00099-7
doi: 10.1016/j.prp.2023.154399
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

154399

Informations de copyright

Copyright © 2023 Elsevier GmbH. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of Interest Declaration All authors declare that there are no financial or personal potential competing interests.

Auteurs

L L Friker (LL)

Institute of Neuropathology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany. Electronic address: Lea.Friker@ukbonn.de.

T Tzaridis (T)

Division of Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany; Tumor Initiation and Maintenance Programme, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.

S J Enkirch (SJ)

Division of Neuroradiology, Department of Radiology, University Hospital Bonn, Bonn, Germany.

C Lüders (C)

Institute of Pathology, University Hospital Bonn, Bonn, Germany.

E Hattingen (E)

Division of Neuroradiology, Department of Radiology, University Hospital Bonn, Bonn, Germany.

G Kristiansen (G)

Institute of Pathology, University Hospital Bonn, Bonn, Germany.

T Goschzik (T)

Institute of Neuropathology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

A Waha (A)

Institute of Neuropathology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

C Lütter (C)

Department of Radiosurgery and Stereotactic Radiotherapy, MediClin Robert Janker Clinic and MediClin MVZ Bonn, Villenstrasse 8, 53129 Bonn, Germany.

J Weller (J)

Division of Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany.

U Herrlinger (U)

Division of Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany.

T Pietsch (T)

Institute of Neuropathology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

M Gessi (M)

Institute of Neuropathology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.

B G Baumert (BG)

Department of Radiosurgery and Stereotactic Radiotherapy, MediClin Robert Janker Clinic and MediClin MVZ Bonn, Villenstrasse 8, 53129 Bonn, Germany; Institute of Radiation-Oncology, Kantonsspital Graubünden, Loestr. 170, 7000 Chur, Switzerland.

G H Gielen (GH)

Institute of Neuropathology, University Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany. Electronic address: Gerrit.Gielen@ukbonn.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH